Cellebrite DI Operating Expenses Growth & History (CLBT)
Cellebrite DI's operating expenses was $334.0M for fiscal 2025.
View full Cellebrite DI company overviewCellebrite DI annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $334.0M | $52.3M | +18.57% |
| 2024 | 2024-12-31 | $281.7M | $43.1M | +18.04% |
| 2023 | 2023-12-31 | $238.6M | $19.8M | +9.04% |
| 2022 | 2022-12-31 | $218.9M | $29.0M | +15.27% |
| 2021 | 2021-12-31 | $189.9M | $42.1M | +28.45% |
| 2020 | 2020-12-31 | $147.8M | $10.3M | +7.46% |
| 2019 | 2019-12-31 | $137.6M | — | — |
Cellebrite DI quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $99.0M | $17.8M | +21.93% |
| Q1 2026 | 2026-03-31 | $96.8M | $19.0M | +24.39% |
| Q4 2025 | 2025-12-31 | $88.3M | — | — |
| Q3 2025 | 2025-09-30 | $86.7M | — | — |
| Q2 2025 | 2025-06-30 | $81.2M | — | — |
| Q1 2025 | 2025-03-31 | $77.8M | — | — |
Cellebrite DI operating expenses trends
Over the last five fiscal years, Cellebrite DI's operating expenses increased from $147.8M to $334.0M, a change of $186.2M. The latest reported quarter, Q2 2026, shows $99.0M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cellebrite DI source filings ↗